291 related articles for article (PubMed ID: 9159168)
21. Down-regulation of protein and mRNA expression for transforming growth factor-beta (TGF-beta1) type I and type II receptors in human prostate cancer.
Guo Y; Jacobs SC; Kyprianou N
Int J Cancer; 1997 May; 71(4):573-9. PubMed ID: 9178810
[TBL] [Abstract][Full Text] [Related]
22. Expression of transforming growth factor (TGF)-beta1, TGF-beta2, and TGF-beta3 and of type I and II TGF-beta receptors during the development of the human fetal ovary.
Schilling B; Yeh J
Fertil Steril; 1999 Jul; 72(1):147-53. PubMed ID: 10428164
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of transforming growth factor beta type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line.
Okamoto M; Oyasu R
Cell Growth Differ; 1997 Aug; 8(8):921-6. PubMed ID: 9269901
[TBL] [Abstract][Full Text] [Related]
24. Ligand-induced downregulation of receptors for TGF-beta in human osteoblast-like cells from adult donors.
Gebken J; Feydt A; Brinckmann J; Notbohm H; Müller PK; Bätge B
J Endocrinol; 1999 Jun; 161(3):503-10. PubMed ID: 10334821
[TBL] [Abstract][Full Text] [Related]
25. Dysregulated expression of transforming growth factor beta and its type-I and type-II receptors in basal-cell carcinoma.
Furue M; Kato M; Nakamura K; Nashiro K; Kikuchi K; Okochi H; Miyazono K; Tamaki K
Int J Cancer; 1997 May; 71(4):505-9. PubMed ID: 9178800
[TBL] [Abstract][Full Text] [Related]
26. Evidence of type I and type II transforming growth factor-beta receptors in central nervous tissues: changes induced by focal cerebral ischemia.
Vivien D; Bernaudin M; Buisson A; Divoux D; MacKenzie ET; Nouvelot A
J Neurochem; 1998 Jun; 70(6):2296-304. PubMed ID: 9603194
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
Guo Y; Kyprianou N
Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
[TBL] [Abstract][Full Text] [Related]
28. Reduced expression of transforming growth factor beta type I receptor contributes to the malignancy of human colon carcinoma cells.
Wang J; Han W; Zborowska E; Liang J; Wang X; Willson JK; Sun L; Brattain MG
J Biol Chem; 1996 Jul; 271(29):17366-71. PubMed ID: 8663343
[TBL] [Abstract][Full Text] [Related]
29. Transforming growth factor-beta enhances adhesion of melanoma cells to the endothelium in vitro.
Teti A; De Giorgi A; Spinella MT; Migliaccio S; Canipari R; Onetti Muda A; Faraggiana T
Int J Cancer; 1997 Sep; 72(6):1013-20. PubMed ID: 9378535
[TBL] [Abstract][Full Text] [Related]
30. Cellular heparan sulfate negatively modulates transforming growth factor-beta1 (TGF-beta1) responsiveness in epithelial cells.
Chen CL; Huang SS; Huang JS
J Biol Chem; 2006 Apr; 281(17):11506-14. PubMed ID: 16492675
[TBL] [Abstract][Full Text] [Related]
31. The expression and action of granulocyte macrophage-colony stimulating factor and its interaction with TGF-beta in endometrial carcinoma.
Ripley D; Tang XM; Ma C; Chegini N
Gynecol Oncol; 2001 May; 81(2):301-9. PubMed ID: 11330966
[TBL] [Abstract][Full Text] [Related]
32. Oncogenic Ki-ras confers a more aggressive colon cancer phenotype through modification of transforming growth factor-beta receptor III.
Yan Z; Deng X; Friedman E
J Biol Chem; 2001 Jan; 276(2):1555-63. PubMed ID: 11029459
[TBL] [Abstract][Full Text] [Related]
33. Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures.
De Groot CJ; Montagne L; Barten AD; Sminia P; Van Der Valk P
J Neuropathol Exp Neurol; 1999 Feb; 58(2):174-87. PubMed ID: 10029100
[TBL] [Abstract][Full Text] [Related]
34. TGF-betas and TGF-beta receptors in atherosclerosis.
McCaffrey TA
Cytokine Growth Factor Rev; 2000; 11(1-2):103-14. PubMed ID: 10708958
[TBL] [Abstract][Full Text] [Related]
35. Alterations of transforming growth factor beta1 (TGF-beta1) and TGFbeta receptor expressions with progression in Dunning rat prostatic adenocarcinoma sublines.
Wikström P; Lindh G; Bergh A; Damber JE
Urol Res; 1999 Jun; 27(3):185-93. PubMed ID: 10422820
[TBL] [Abstract][Full Text] [Related]
36. Human mast cell migration in response to members of the transforming growth factor-beta family.
Olsson N; Piek E; ten Dijke P; Nilsson G
J Leukoc Biol; 2000 Mar; 67(3):350-6. PubMed ID: 10733095
[TBL] [Abstract][Full Text] [Related]
37. Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor-beta.
Douglas RS; Capocasale RJ; Lamb RJ; Nowell PC; Moore JS
Blood; 1997 Feb; 89(3):941-7. PubMed ID: 9028325
[TBL] [Abstract][Full Text] [Related]
38. Activation of a serine/threonine kinase signaling pathway by transforming growth factor type beta.
Atfi A; Lepage K; Allard P; Chapdelaine A; Chevalier S
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12110-4. PubMed ID: 8618854
[TBL] [Abstract][Full Text] [Related]
39. Epithelial rat thyroid cell clones, escaping from transforming growth factor beta negative growth control, are still inhibited by this factor in the ability to trap iodide.
Coppa A; Mincione G; Mammarella S; Ranieri A; Colletta G
Cell Growth Differ; 1995 Mar; 6(3):281-90. PubMed ID: 7794796
[TBL] [Abstract][Full Text] [Related]
40. Expression of transforming growth factor beta1, transforming growth factor type I and II receptors, and TNF-alpha in the mucosa of the small intestine in infants with food protein-induced enterocolitis syndrome.
Chung HL; Hwang JB; Park JJ; Kim SG
J Allergy Clin Immunol; 2002 Jan; 109(1):150-4. PubMed ID: 11799382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
